Search Results - "EBERLING, J. L"

Refine Results
  1. 1

    Safety and tolerability of putaminal AADC gene therapy for Parkinson disease by CHRISTINE, C. W, STARR, P. A, LARSON, P. S, EBERLING, J. L, JAGUST, W. J, HAWKINS, R. A, VANBROCKLIN, H. F, WRIGHT, J. F, BANKIEWICZ, K. S, AMINOFF, M. J

    Published in Neurology (17-11-2009)
    “…In Parkinson disease (PD), the benefit of levodopa therapy becomes less marked over time, perhaps because degeneration of nigrostrial neurons causes…”
    Get full text
    Journal Article
  2. 2

    Results from a phase I safety trial of hAADC gene therapy for Parkinson disease by EBERLING, J. L, JAGUST, W. J, CHRISTINE, C. W, STARR, P, LARSON, P, BANKIEWICZ, K. S, AMINOFF, M. J

    Published in Neurology (20-05-2008)
    “…In a primate model of Parkinson disease (PD), intrastriatal infusion of an adeno-associated viral (AAV) vector containing the human aromatic l-amino acid…”
    Get full text
    Journal Article
  3. 3

    Preliminary evidence that estrogen protects against age-related hippocampal atrophy by Eberling, J.L., Wu, C., Haan, M.N., Mungas, D., Buonocore, M., Jagust, W.J.

    Published in Neurobiology of aging (01-09-2003)
    “…Few studies have examined gender differences in hippocampal volumes, and the potential effect of estrogen on these measures has not been well studied. We used…”
    Get full text
    Journal Article
  4. 4

    Brain structure and cognition in a community sample of elderly latinos by WU, C. C, MUNGAS, D, PETKOV, C. I, EBERLING, J. L, ZRELAK, P. A, BUONOCORE, M. H, BRUNBERG, J. A, HAAN, M. N, JAGUST, W. J

    Published in Neurology (13-08-2002)
    “…Previous studies have found that hippocampal atrophy and white matter hyperintensities (WMH) on MRI are linked to cognitive impairment and dementia. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease by Reed, B. R., Eberling, J. L., Mungas, D., Weiner, M. W., Jagust, W. J.

    Published in Annals of neurology (01-09-2000)
    “…Patients with extensive subcortical cerebrovascular disease may have impaired memory, often despite the absence of medial temporal or diencephalic strokes. In…”
    Get full text
    Journal Article
  7. 7

    Effect of estrogen on cerebral glucose metabolism in postmenopausal women by EBERLING, J. L, REED, B. R, COLEMAN, J. E, JAGUST, W. J

    Published in Neurology (26-09-2000)
    “…PET was used to evaluate the effect of estrogen use on regional cerebral glucose metabolism in postmenopausal women. Women receiving estrogen replacement…”
    Get full text
    Journal Article
  8. 8

    Brain function and cognition in a community sample of elderly latinos by JAGUST, W. J, EBERLING, J. L, WU, C. C, FINKBEINER, A, MUNGAS, D, VALK, P. E, HAAN, M. N

    Published in Neurology (13-08-2002)
    “…Previous studies using PET to measure cerebral glucose metabolism in AD have found metabolic reductions in the temporoparietal and posterior cingulate cortices…”
    Get full text
    Journal Article
  9. 9

    Tremor Is Associated with PET Measures of Nigrostriatal Dopamine Function in MPTP-Lesioned Monkeys by Eberling, J.L., Pivirotto, P., Bringas, J., Bankiewicz, K.S.

    Published in Experimental neurology (01-10-2000)
    “…Unilateral intracarotid artery (ICA) MPTP infusion, along with sequential systemic doses of MPTP, produces near complete degeneration of the nigrostriatal…”
    Get full text
    Journal Article
  10. 10

    PET studies of functional compensation in a primate model of Parkinsonʼs disease by Eberling, J L, Bankiewicz, K S, Jordan, S, VanBrocklin, H F, Jagust, W J

    Published in Neuroreport (18-08-1997)
    “…MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a neurotoxin that produces degeneration of nigrostriatal dopaminergic neurons and a chronic parkinsonian…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Reduced temporal lobe blood flow in Alzheimer's disease by Eberling, J L, Jagust, W J, Reed, B R, Baker, M G

    Published in Neurobiology of aging (01-07-1992)
    “…We used single photon emission computed tomography with the blood flow tracer [123I]N-isopropyl-p-iodoamphetamine (IMP) to study regional cerebral blood flow…”
    Get more information
    Journal Article
  13. 13

    Cerebral Glucose Metabolism and Memory in Aged Rhesus Macaques by Eberling, J.L, Roberts, J.A, Rapp, P.R, Tuszynski, M.H, Jagust, W.J

    Published in Neurobiology of aging (01-07-1997)
    “…Positron emission tomography and the glucose metabolic tracer [ 18F]fluorodeoxyglucose were used to evaluate the relationship between regional cerebral…”
    Get full text
    Journal Article
  14. 14

    A methodology for specifying PET VOIs using multimodality techniques by Klein, G.J., Teng, X., Jagust, W.J., Eberling, J.L., Acharya, A., Reutter, B.W., Huesman, R.H.

    Published in IEEE transactions on medical imaging (01-08-1997)
    “…Volume-of-interest (VOI) extraction for radionuclide and anatomical measurements requires correct identification and delineation of the anatomical feature…”
    Get full text
    Journal Article
  15. 15

    A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes by Eberling, Jamie L., Jagust, William J., Taylor, Scott, Bringas, John, Pivirotto, Phillip, VanBrocklin, Henry F., Bankiewicz, Krys S.

    Published in Brain research (14-09-1998)
    “…Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [ 18 F] 6-fluoro- l- m-tyrosine (FMT) were used to evaluate the relationship…”
    Get full text
    Journal Article
  16. 16

    Brain perfusion imaging predicts survival in Alzheimer's disease by JAGUST, W. J, HAAN, M. N, REED, B. R, EBERLING, J. L

    Published in Neurology (01-10-1998)
    “…The variability of disease course in patients diagnosed with AD makes prediction of survival difficult, despite the identification of numerous predictors to…”
    Get full text
    Journal Article
  17. 17

    Cortical glucose metabolism in Parkinson's disease without dementia by Eberling, J L, Richardson, B C, Reed, B R, Wolfe, N, Jagust, W J

    Published in Neurobiology of aging (01-05-1994)
    “…There have been several reports of decreased regional cerebral metabolic rates for glucose (rCMRglc) in Parkinson's disease (PD), although others find no…”
    Get more information
    Journal Article
  18. 18

    Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study by Biegon, A, Eberling, J L, Richardson, B C, Roos, M S, Wong, S T, Reed, B R, Jagust, W J

    Published in Neurobiology of aging (01-07-1994)
    “…The involvement of the corpus callosum in aging and Alzheimer's disease (AD) is not clear. We measured cross sectional areas of the entire corpus callosum…”
    Get more information
    Journal Article
  19. 19

    Iodine-123-5-Iodo-6-Nitroquipazine: SPECT Radiotracer to Image the Serotonin Transporter by Jagust, William J, Eberling, Jamie L, Biegon, Anat, Taylor, Scott E, VanBrocklin, Henry F, Jordan, Shaun, Hanrahan, Stephen M, Roberts, Jeffrey A, Brennan, Kathleen M, Mathis, Chester A

    Published in The Journal of nuclear medicine (1978) (01-07-1996)
    “…Because serotonergic function has been implicated in the pathophysiology of a number of diseases of the nervous system, efforts to image this system in vivo…”
    Get full text
    Journal Article
  20. 20

    Dopamine transporter loss and clinical changes in MPTP-lesioned primates by Eberling, Jamie L, Bankiewicz, Krzysztof S, Pivirotto, Phillip, Bringas, John, Chen, Karen, Nowotnik, David P, Steiner, Joseph P, Budinger, Thomas F, Jagust, William J

    Published in Brain research (19-06-1999)
    “…Single photon emission computed tomography (SPECT) and the dopamine (DA) transporter tracer, 2 beta-carboxymethoxy-3 beta-(4-iodophenyl)tropane ([123I]β-CIT),…”
    Get full text
    Journal Article